University research institution
Appears in 1 story · Last updated Nov 16, 2026
Led the study and ELIXIR trial
Fourteen people with primary aldosteronism took an experimental aldosterone-blocking drug for 6 to 12 months. Two years after stopping, their systolic blood pressure averaged 25 points lower and a hormone marker of excess aldosterone was 99% below baseline.
Updated 43 minutes ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?